ICF International (ICFI) Competitors

Apollo Medical (NASDAQ:AMEH) and ICF International (NASDAQ:ICFI) are both mid-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, community ranking, profitability, institutional ownership, valuation, risk, dividends and media sentiment.

Is AMEH or ICFI more profitable?

ICF International has a net margin of 4.74% compared to ICF International's net margin of 3.56%. Apollo Medical's return on equity of 14.42% beat ICF International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Apollo Medical	3.56%	9.90%	5.51%
ICF International	4.74%	14.42%	6.33%

Does the MarketBeat Community believe in AMEH or ICFI?

ICF International received 207 more outperform votes than Apollo Medical when rated by MarketBeat users. Likewise, 67.38% of users gave ICF International an outperform vote while only 60.79% of users gave Apollo Medical an outperform vote.

Company	Underperform	Outperform
Apollo Medical	Outperform Votes 138 60.79%	Underperform Votes 89 39.21%
ICF International	Outperform Votes 345 67.38%	Underperform Votes 167 32.62%

Which has more risk and volatility, AMEH or ICFI?

Apollo Medical has a beta of 1.04, indicating that its stock price is 4% more volatile than the S&P 500. Comparatively, ICF International has a beta of 0.61, indicating that its stock price is 39% less volatile than the S&P 500.

Do insiders & institutionals have more ownership in AMEH or ICFI?

35.9% of Apollo Medical shares are owned by institutional investors. Comparatively, 94.1% of ICF International shares are owned by institutional investors. 8.5% of Apollo Medical shares are owned by company insiders. Comparatively, 1.4% of ICF International shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Do analysts rate AMEH or ICFI?

Apollo Medical presently has a consensus target price of $47.20, suggesting a potential upside of 15.63%. ICF International has a consensus target price of $162.75, suggesting a potential upside of 15.41%. Given ICF International's stronger consensus rating and higher possible upside, equities analysts plainly believe Apollo Medical is more favorable than ICF International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Apollo Medical	0 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.80
ICF International	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75

Which has better earnings and valuation, AMEH or ICFI?

ICF International has higher revenue and earnings than Apollo Medical. ICF International is trading at a lower price-to-earnings ratio than Apollo Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Apollo Medical	$1.14B	2.08	$45.17M	$1.00	40.82
ICF International	$1.96B	1.34	$82.61M	$4.92	28.53

Does the media favor AMEH or ICFI?

In the previous week, ICF International had 14 more articles in the media than Apollo Medical. MarketBeat recorded 16 mentions for ICF International and 2 mentions for Apollo Medical. ICF International's average media sentiment score of 0.88 beat Apollo Medical's score of 0.39 indicating that Apollo Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Apollo Medical	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
ICF International	3 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

ICF International beats Apollo Medical on 10 of the 18 factors compared between the two stocks.